2Li RK,Ciblak MA,Nordoff N,et al.In vitro activities of voriconazole,itraconazole,and amphotericin B against blastomyces dermatitidis,coccidioides immitis,and histoplasma capsulatum[J].Antimicrobial Agents and Chemotherapy,2000,44(6):1 734. 被引量：1
3Lewis RE,Wiederhold NP,Klesper ME.In vitro pharmacodynamics of amphotericin B,itraconazole,and voriconazole against aspergillus,fusarium,and scedosporium spp[J].Antimicrobial Agents and Chemotherapy,2005,49(3):945. 被引量：1
4Lass-Florl C,Nagl M,Speth C,et al.Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining[J].Antimicrobial Agents and Chemotherapy,2001,45(1):124. 被引量：1
5Herbrecht R,Denning DW,Patterson TF.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J].The New England Journal of Medicine,2002,347(6):408. 被引量：1
6Venkataramanan R,Shimin Z,Gayowski T,et al.Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microomes[J].Antimicrobial Agents and Chemotherapy,2002,46(9):3 091. 被引量：1
7Pelletier R,Loranger L,Marcotte H,et al.Voriconazole and fluconazole susceptibility of candida isolates[J].Journal of Medical Microbiology,2002,51(6):479. 被引量：1
8Pfaller MA,Messer SA,Hollis RJ,et al.In vitro susceptibilities of candida bloodstream isolates to the new triazole antifungal agents BMS-207147,Sch 56592,and voriconazole[J].Antimicrobial Agents and Chemotherapy,1998,42(12):3 242. 被引量：1
9Chávez M,Bernal S,Valverde A.In-vitro activity of voriconazole (UK-109,496),LY303366 and other antifungal agents against oral candida spp[J].Journal of Antimicrobial Chemotherapy,1998,42(1):161. 被引量：1
6Sutton SS. Voriconazole: a new triazole antifungal agent[J].Continuing Education Credit,2003,28(4):268 被引量：1
7Espinel IA. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi[J]. J Clin Microbiol,2001,39(3):954 被引量：1
8Crrillo AJ, Guarro J. In vitro activities of four novel triazoles against scedosporium spp[J].Antimicrob Agents Chemother,2001,45(7):2151 被引量：1
9Klepser M, Malone D. Evaluation ofvoriconazole pharmacodynamics using timekill methodology[J].Antimicrob Agents Chemother ,2000; 44:1917 被引量：1
10Herbrecht R, Denning DW, Patterson TF, et al. The hydroxylation of omeprazole correlates with S-mephytion metabolism:A population study[J]. Clin Pharmacol,1995; 57:662 被引量：1
